Interleukin Genetics, (ILIU) Releases Quarterly Earnings Results, Meets Expectations
Interleukin Genetics, (NASDAQ:ILIU) announced its earnings results on Thursday. The company reported ($0.01) earnings per share for the quarter, meeting the analysts’ consensus estimate of ($0.01), ARN reports.
Interleukin Genetics, (NASDAQ:ILIU) opened at 0.25 on Thursday. Interleukin Genetics, has a 52 week low of $0.20 and a 52 week high of $0.44. The stock has a 50-day moving average of $0.2 and a 200-day moving average of $0.30. The company’s market cap is $30.6 million.
Interleukin Genetics, Inc is a personalized health company that develops genetic tests. The Company has two primary focus areas to its business.
Receive News & Ratings for Interleukin Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interleukin Genetics and related companies with Analyst Ratings Network's FREE daily email newsletter.